NEW YORK (GenomeWeb News) – Roche announced today that it has licensed technology from NuGen Technologies that will be included in Roche’s LightCycler RNA Pre-Amplification Kit, which will be launched in the third quarter of 2008.
 
Under the co-exclusive agreement, NuGen will supply components for the kit and has provided Roche with limited access to NuGen’s Ovation technology, which enables small and partially degraded RNA samples to be amplified into micrograms of cDNA.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.